The supercomputer identified a different type of cancer than the one doctors were currently treating for a patient in Japan.
The software currently enables people living with epilepsy to track their seizures and researchers want to develop the program into a seizure detector as well.
The company also said its scientists are working with Icahn School of Medicine at Mount Sinai to test the technology on prostate cancer.
The U-M School of Public Health will collaborate with Vanderbilt University’s Data and Research Support Center to organize and analyze data for the effort.
Cancer treatments, drug discovery, genome sequencing, president Obama’s Precision Medicine Initiative, are all driving big spending for personalized and precision medicine.
NantHealth, University of Utah partner on genome work to advance precision medicine for common diseases
The organizations kick off a project to recruit 1,000 people for whole genome sequencing using the NantHealth platform and the university's population health database.
Researchers in California regularly use a database to search for trends, confirm potential cancer clusters and identify disparities in screening and outcomes.
Scientists at Weill Cornell Medicine say the new genome sequencing test to detect mutations can guide precision cancer treatment with more than 95 percent accuracy.
Population health management, EHRs and biosensing technologies were also among the top investment areas.
Carefluence OpenAPI proved to be compliant with Office of the National Coordinator criteria by using the FHIR standard. The application programming interface also can used with EHRs for open access.